Anti-lipaemic effect of Desopimon in obesity and in diabetes mellitus accompanied by obesity.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000924:Anticholesteremic Agents / Q000627:therapeutic use*; D001067:Appetite Depressants / Q000627:therapeutic use*; D001798:Blood Proteins / Q000032:analysis; D001835:Body Weight / Q000187:drug effects; D002745:Chlorphentermine / Q000627:therapeutic use; D002784:Cholesterol / Q000097:blood / Q000652:urine; D003920:Diabetes Mellitus / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007657:Ketone Bodies / Q000097:blood; D008055:Lipids / Q000097:blood; D008297:Male; D008875:Middle Aged; D009765:Obesity / Q000188:drug therapy*; D010627:Phenethylamines / Q000627:therapeutic use*
D000924:Anticholesteremic Agents; D001067:Appetite Depressants; D001798:Blood Proteins; D007657:Ketone Bodies; D008055:Lipids; D010627:Phenethylamines; D002784:Cholesterol; D002745:Chlorphentermine